The Rush Approach to Transoral Robotic Surgery
We know head and neck cancer tumors are often difficult to reach and challenging to treat, heavily affecting your quality of life. Transoral robotic surgery is a minimally invasive option that might be right for you that's still highly effective.
Using transoral robotic surgery, or TORS, your provider can view, diagnose and treat tumors in the throat, larynx (voice box) and oropharynx (base of the tongue and tonsils) — including the HPV-related head and neck cancers that are increasingly common in young adults.
TORS allows you to return to normal activity more quickly, with fewer complications, and reduces the need for chemotherapy and radiation. And your overall outcomes are comparable to a more invasive open surgery.
Meet our TORS providers
Rush Excellence in Transoral Robotic Surgery
- Minimizing need for cancer treatment: If your provider removes your tumor with TORS, it may minimize your need for radiation and chemotherapy — which can have long-term effects on speech, swallowing and your overall quality of life.
- A leader in the Midwest: Head and neck cancer surgeons at Rush are some of the leading TORS experts in Chicago. In fact, our team has used TORS since it was a developing technology, and today, Rush is one of the Midwest's leading centers for TORS.
- With you for the long run: At Rush, we treat you, not just the cancer. Our multidisciplinary care plans focus not only on how to treat the tumor, but how to address the effects of treatments such as chemotherapy, radiation and surgery so you can live your life to the fullest.
U.S. News & World Report ranked Rush University Medical Center among the best in the nation for ENT care.
